# Certolizumab pegol in rheumatoid arthritis patients with low to moderate activity: the CERTAIN double-blind, randomised, placebo-controlled trial

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/certolizumab-pegol-in-rheumatoid-arthritis-patients-with-low-to-moderate/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Josef S Smolen,Paul Emery,Gianfranco Ferraccioli,Włodzimierz Samborski,Françis Berenbaum,Owain Davies,Willem Koetse,O. Purcaru,B. Bennett,Harald Burkhardt |
| Citations | 112 |
| DOI | 10.1136/annrheumdis-2013-204632 |
| Fields | Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | https://ard.bmj.com/content/annrheumdis/74/5/843.full.pdf |
| OpenAlex ID | https://openalex.org/W2131592263 |
| PMID | 24431394 |
| Type | article |
| Year | 2014 |

## Paper authors

- [Włodzimierz Samborski](https://scholariq.org/researchers/w-odzimierz-samborski/)

## Paper journal

- [Annals of the Rheumatic Diseases](https://scholariq.org/journals/annals-of-the-rheumatic-diseases/)

## Paper primary topic

- [Rheumatoid Arthritis Research and Therapies](https://scholariq.org/topics/rheumatoid-arthritis-research-and-therapies/)

## Paper topics

- [Rheumatoid Arthritis Research and Therapies](https://scholariq.org/topics/rheumatoid-arthritis-research-and-therapies/)
- [Spondyloarthritis Studies and Treatments](https://scholariq.org/topics/spondyloarthritis-studies-and-treatments/)
- [Autoimmune and Inflammatory Disorders Research](https://scholariq.org/topics/autoimmune-and-inflammatory-disorders-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.